Literature DB >> 10898923

Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism.

A Parsian1, C R Cloninger, Z H Zhang.   

Abstract

Dopaminergic pathway genes are considered as candidate genes for several neuropsychiatric diseases including severe alcoholism. Since 1990, there have been numerous reports of conflicting association studies of the Taq I A allele of the dopamine D2 receptor (DRD2) gene and alcoholism. Functional and structural variations in candidate genes offer more direct evaluation of their role in the development of a disorder. To determine the role of such variations in the DRD2 gene in the development of alcoholism subtypes, we screened a sample of 173 alcoholics and 88 normal controls with the A-241G and -141C Ins/Del variations in the promoter region and C311G variation in exon 7 of the DRD2 gene. Comparison of alcoholics with normal controls for allele frequency differences of these three variations was negative. Allele frequency differences of the two variations in the promoter region between type II alcoholics, alcoholics with medical complications, and normal controls were not significant. There was linkage disequilibrium only between -141 Ins/Del and Taq I D polymorphisms. We conclude that the functional and structural variations in DRD2 gene do not play a major role in the development of alcoholism subtypes in our sample.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898923     DOI: 10.1002/1096-8628(20000612)96:3<407::aid-ajmg32>3.0.co;2-1

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  An overview of the genetics of substance use disorders.

Authors:  H M Lachman
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

3.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

4.  The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

Authors:  Jacquelyn L Meyers; Emma Nyman; Anu Loukola; Richard J Rose; Jaakko Kaprio; Danielle M Dick
Journal:  Addict Biol       Date:  2012-09-12       Impact factor: 4.280

Review 5.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

6.  The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans.

Authors:  Yanlei Du; Yu-Jui Yvonne Wan
Journal:  Alcohol Clin Exp Res       Date:  2009-09-17       Impact factor: 3.455

7.  Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

Authors:  Ying Zhang; Alessandro Bertolino; Leonardo Fazio; Giuseppe Blasi; Antonio Rampino; Raffaella Romano; Mei-Ling T Lee; Tao Xiao; Audrey Papp; Danxin Wang; Wolfgang Sadée
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

8.  Drd2 expression in the high alcohol-preferring and low alcohol-preferring mice.

Authors:  Paula J Bice; Tiebing Liang; Lili Zhang; Wendy N Strother; Lucinda G Carr
Journal:  Mamm Genome       Date:  2008-01-23       Impact factor: 2.957

Review 9.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

10.  Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.

Authors:  Emma Childs; Christa Hohoff; Jürgen Deckert; Ke Xu; Judith Badner; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2008-02-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.